# US 2017/0245838 A1 · Methods and systems for controlled deployment of needles in tissue

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0245838 A1
- Document ID: US20170245838A1
- Status: Published application
- Kind: A1
- Application number: 15/595,659
- Filed: 2017-05-15
- Published: 2017-08-31
- Earliest claimed: 2007-10-12
- Assignees: Gynesonics, Inc.
- Applicants: Gynesonics, Inc.
- Inventors: Michael MUNROW; Jordan BAJOR; Malcom G. MUNRO
- Web page: https://patentgrep.com/patent/US20170245838A1

## CPC

- A61B 90/36: {Image-producing devices or illumination devices not otherwise provided for}
- A61B 8/0841: {for locating instruments}
- A61B 8/12: in body cavities or body tracts, e.g. by using catheters
- A61B 10/0045: {Devices for taking samples of body liquids}
- A61B 18/1477: {Needle-like probes}
- A61B 34/10: Computer-aided planning, simulation or modelling of surgical operations
- A61M 5/46: having means for controlling depth of insertion
- A61B 90/11: with guides for needles or instruments, e.g. arcuate slides or ball joints
- A61B 2010/045: {Needles (pointed biopsy devices with vacuum aspiration A61B10/0283)}
- A61B 2018/1425: {Needle}
- A61B 2034/107: {Visualisation of planned trajectories or target regions}
- A61B 2090/378: {using ultrasound}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

Needles are deployed in tissue under direct ultrasonic or other imaging. To aid in deploying the needle, a visual needle guide is projected on to the image prior to needle deployment. Once the needle guide is properly aligned, the needle can be deployed. After needle deployment, a safety boundary and treatment region are projected on to the screen. After confirming that the safety boundary and treatment regions are sufficient, the patient can be treated using the needle.

## Claims

### Claim 1

A method for treating uterine anatomy, the method comprising:
positioning a probe proximate to the uterine anatomy;
using the probe to provide an image of the uterine anatomy; and
projecting a projected treatment region on the image based on a position of a tissue treatment device, the projected treatment region including at least a portion of uterine anatomy to be treated;
projecting a safety boundary on the image based on the position of the tissue treatment device;
adjusting the safety boundary on the image so that a sensitive anatomical structure is outside of the safety boundary; and
treating the uterine anatomy with the tissue treatment device.

### Claim 2 (depends on 1)

The method of claim 1, wherein the tissue treatment device comprises a deployable needle configured to ablate the uterine anatomy.

### Claim 3 (depends on 2)

The method of claim 2, wherein at least one of the projected treatment region and the safety boundary is based on a position of the deployable needle prior to the needle being deployed.

### Claim 4 (depends on 2)

The method of claim 2, wherein at least one of the projected treatment region and the safety boundary is based on a position of the deployable needle after the needle is deployed.

### Claim 5 (depends on 1)

The method of claim 1, wherein the tissue treatment device comprises an array of RF ablation needles.

### Claim 6 (depends on 1)

The method of claim 1, wherein the probe comprises the tissue treatment device.

### Claim 7 (depends on 1)

The method of claim 1, wherein the probe and the tissue treatment device are delivered transvaginally into a uterus of a subject comprising the uterine anatomy.

### Claim 8 (depends on 1)

The method of claim 1, wherein using the probe to provide the image of the uterine anatomy comprises using the probe to provide a real time image of a uterine fibroid to be treated, wherein the projected treatment region includes at least a portion of the uterine fibroid, wherein the sensitive anatomical structure comprises seorsa, and wherein treating the uterine anatomy with the tissue treatment device comprises treating the uterine fibroid.

### Claim 9

A method for treating uterine anatomy, the method comprising:
positioning a probe proximate to the uterine anatomy;
using the probe to provide an image of the uterine anatomy; and
projecting a safety boundary on the image based on a position of a tissue treatment device;
adjusting a position of the tissue treatment device so that a sensitive anatomical structure is outside of the safety boundary on the image; and
treating the uterine anatomy with the tissue treatment device.

### Claim 10 (depends on 9)

The method of claim 9, wherein the tissue treatment device comprises a deployable needle configured to ablate the uterine anatomy.

### Claim 11 (depends on 10)

The method of claim 10, wherein the safety boundary is based on a position of the deployable needle prior to the needle being deployed.

### Claim 12 (depends on 10)

The method of claim 10, wherein the safety boundary is based on a position of the deployable needle after the needle is deployed.

### Claim 13 (depends on 9)

The method of claim 9, wherein the tissue treatment device comprises an array of RF ablation needles.

### Claim 14 (depends on 9)

The method of claim 9, wherein probe comprises the tissue treatment device.

### Claim 15 (depends on 9)

The method of claim 9, wherein the probe and the tissue treatment device are delivered transvaginally into a uterus of a subject comprising the uterine anatomy.

### Claim 16 (depends on 9)

The method of claim 9, wherein using the probe to provide the image of the uterine anatomy comprises using the probe to provide a real time image of a uterine fibroid to be treated, wherein the sensitive anatomical structure comprises seorsa, and wherein treating the uterine anatomy with the tissue treatment device comprises treating the uterine fibroid.

### Claim 17

A method for treating uterine anatomy, the method comprising:
positioning a probe proximate to the uterine anatomy;
using the probe to provide an image of the uterine anatomy; and
projecting a projected treatment region on the image based on a position of a tissue treatment device, the projected treatment region including at least a portion of uterine anatomy to be treated; and
treating the uterine anatomy with the tissue treatment device.

### Claim 18 (depends on 17)

The method of claim 17, wherein the tissue treatment device comprises a deployable needle configured to ablate the uterine anatomy.

### Claim 19 (depends on 18)

The method of claim 18, wherein the projected treatment region is based on a position of the deployable needle prior to the needle being deployed.

### Claim 20 (depends on 18)

The method of claim 18, wherein the projected treatment region is based on a position of the deployable needle after the needle is deployed.

### Claim 21 (depends on 17)

The method of claim 17, wherein the tissue treatment device comprises an array of RF ablation needles.

### Claim 22 (depends on 17)

The method of claim 17, wherein probe comprises the tissue treatment device.

### Claim 23 (depends on 17)

The method of claim 17, wherein the probe and the tissue treatment device are delivered transvaginally into a uterus of a subject comprising the uterine anatomy.

### Claim 24 (depends on 17)

The method of claim 17, wherein using the probe to provide the image of the uterine anatomy comprises using the probe to provide a real time image of a uterine fibroid to be treated, and wherein treating the uterine anatomy with the tissue treatment device comprises treating the uterine fibroid.

### Claim 25

A method for treating uterine anatomy, the method comprising:
overlaying an image of the uterine anatomy including an anatomical feature to be treated with projected needle treatment information of a tissue treatment device positioned proximate to the uterine anatomy, wherein the tissue treatment device comprises a deployable needle, and wherein the projected needle treatment information is based on a projected position of the needle prior to the needle being deployed into the uterine anatomy;
aligning the projected needle treatment information on the image with the anatomical feature to be treated; and
treating the anatomical feature by delivering energy through the deployable needle.

### Claim 26 (depends on 25)

The method of claim 25, wherein the anatomical feature to be treated comprises a uterine fibroid.

### Claim 27 (depends on 25)

The method of claim 25, wherein the projected treatment region comprises a projected needle deployment path.

### Claim 28 (depends on 25)

The method of claim 25, wherein the projected treatment region comprises a projected therapy region based on the projected needle position prior to the needle being deployed into the uterine anatomy.

### Claim 29 (depends on 28)

The method of claim 28, wherein the projected treatment region comprises a safety boundary on the projected needle position prior to the needle being deployed into the uterine anatomy.

### Claim 30 (depends on 25)

The method of claim 25, further comprising overlaying the image of the uterine anatomy with a projected therapy region after the needle is deployed into the uterine anatomy.
